Play your own investment version of the popular squid game, on your own terms.
Last call to join our free webinar!
We offer a slew of updates from five companies to whet your appetite.
Although the CPF offers a decent return for parking your funds, here are three companies that offer higher dividend yields.
Fintech companies promise to usher in a new era of convenience and speed. Here’s why you should latch on to this fast-growing trend.
We compare two industrials with the same sponsor to determine which makes a better investment choice.
Rights issues are often used as a method for companies to raise money. Should investors reserve some money to apply for them?
Not all REITs fared poorly during this downturn. Here are five that reported a sharp year on year jump in their distributions.
This week’s round-up talks about a REIT acquisition cum divestment, a fintech player bidding for a Malaysian digital bank licence, and a divestment by a real estate giant.
Blue-chip conglomerate Keppel is embarking on a potential combination that could transform the company. Here are four things you should know.
The healthcare glove manufacturer continues to announce amazing numbers.
These companies can be relied upon for a steady stream of income during these turbulent times.
The financial technology company has failed in its bid to win a digital banking licence.
Moderna and BioNTech’s share prices have increased by 621% and 237% year-to-date. Is it too late to get in on these COVID-19 vaccine frontrunners?